Syngenis joins WA research heavyweights in RNA medicine push
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.
How 2 newspapers cover this story
Syngenis joins WA research heavyweights in RNA medicine push
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.
Syngenis joins WA research heavyweights in RNA medicine push
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.
Coverage details
2 outlets from Australia are covering this story: The Sydney Morning Herald and The Age. The Sydney Morning Herald and The Age published it almost at the same time, on November 19, 2026.
Key names in the coverage: Syngenis Labs, RNA and ASX.


